SMARTAB^® is a tablet lubricant designed for formulations in which other lubricants lead to formulation and/or manufacturing challenges. As opposed to the frequently used lubricant, magnesium stearate, SMARTAB^® offers the following advantages:

• Better API compatibility
• Robustness to over-lubrication
• No adverse effect on bioavailability
• Improved appearance of effervescent solutions.

SMARTAB^® helps to accelerate product development and is particularly well suited for high-speed directly compressible granules and tablets.

Lot of Reported APIs having incompatibilities with magnesium stearate includes but not limited to : Azathioprin, Cefaclor, Cilazapril, Clopidogrel acetate, Dicofenac, Fosinopril, Ibuprofen, Ketorolac, Levofloxacin, Nifedipine, Omeprazole, Ramipril, Trandolapril and more…..

SMARTAB Benefits:

• Improved drug stability
• Faster dissolution rates
• Harder tablets
• Protection from over-blending
• Faster formulation development and scale-up
• Enhanced lubrication efficiency

Get A Quote!